[HTML][HTML] A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
…, A Sheikh-Omar, KD Silué, SB Sirima… - … England Journal of …, 2016 - Mass Medical Soc
Background Recent gains in reducing the global burden of malaria are threatened by the
emergence of Plasmodium falciparum resistance to artemisinins. The discovery that mutations …
emergence of Plasmodium falciparum resistance to artemisinins. The discovery that mutations …
[HTML][HTML] Genome-wide and fine-resolution association analysis of malaria in West Africa
…, EM Riley, A Sakuntabhai, P Singhasivanon, S Sirima… - Nature …, 2009 - nature.com
We report a genome-wide association (GWA) study of severe malaria in The Gambia. The
initial GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a …
initial GWA scan included 2,500 children genotyped on the Affymetrix 500K GeneChip, and a …
Early treatment of childhood fevers with pre‐packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso
SB Sirima, A Konate, AB Tiono… - Tropical Medicine & …, 2003 - Wiley Online Library
In rural, malaria‐endemic Burkina Faso, we evaluated the impact of the use of pre‐packaged
antimalarial drugs (PPAM), by mothers in the home, on the progression of disease in …
antimalarial drugs (PPAM), by mothers in the home, on the progression of disease in …
[HTML][HTML] Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity
A detailed understanding of the human infectious reservoir is essential for improving
malaria transmission-reducing interventions. Here we report a multi-regional assessment of …
malaria transmission-reducing interventions. Here we report a multi-regional assessment of …
Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal …
…, S Bosomprah, P Milligan, SB Sirima - Infection and …, 2008 - Am Soc Microbiol
There is longstanding evidence that immunoglobulin G (IgG) has a role in protection against
clinical malaria, and human antibodies of the cytophilic subclasses are thought to be …
clinical malaria, and human antibodies of the cytophilic subclasses are thought to be …
Resistance to malaria through structural variation of red blood cell invasion receptors
…, EC Bougouma, VD Mangano, D Modiano, SB Sirima… - Science, 2017 - science.org
INTRODUCTION Malaria parasites cause human disease by invading and replicating inside
red blood cells. In the case of Plasmodium falciparum, this can lead to severe forms of …
red blood cells. In the case of Plasmodium falciparum, this can lead to severe forms of …
A review of 65 years of human adenovirus seroprevalence
…, AR Ouoba, S Salazar Arenas, SB Sirima… - Expert review of …, 2019 - Taylor & Francis
Introduction: Human adenovirus (HAdV)-derived vectors have been used in numerous pre-clinical
and clinical trials during the last 40 years. Current research in HAdV-based vaccines …
and clinical trials during the last 40 years. Current research in HAdV-based vaccines …
[HTML][HTML] Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in …
…, S Cousens, PJ Milligan, SB Sirima… - PLoS …, 2011 - journals.plos.org
Background Intermittent preventive treatment of malaria in children (IPTc) is a promising
new approach to the control of malaria in areas of seasonal malaria transmission but it is not …
new approach to the control of malaria in areas of seasonal malaria transmission but it is not …
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum …
…, MVVC group, O Leroy, B Cisse, S Sirima… - Science translational …, 2015 - science.org
Protective immunity to the liver stage of the malaria parasite can be conferred by vaccine-induced
T cells, but no subunit vaccination approach based on cellular immunity has shown …
T cells, but no subunit vaccination approach based on cellular immunity has shown …
[HTML][HTML] Protection against malaria by MSP3 candidate vaccine
SB Sirima, S Cousens, P Druilhe - New England Journal of …, 2011 - Mass Medical Soc
… s.sirima.cnlp@fasonet.bf … Sirima SB, Tiono AB, Ouedraogo A, et al. Safety and
immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 …
immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 …
